Cynthia Smith, Director at Akebia Therapeutics, Inc. (AKBA), sold 9,134 shares at $12.10 ($111K) on 2020-06-08, disclosed to the SEC on 2020-06-09.
Open-market sale of $111k AKBA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.10 | 4,567 | $55K | 50.0% |
| 2 | $12.10 | 4,567 | $55K | 50.0% |
| Total | $12.10 avg | 9,134 | $111K | 100% |